CTI-168

N/A

Report date: 2024/12/18 13:39:48
NME

Base Information

Drug NameCTI-168
Drug Alias NameCTI-168
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCytokines inhibitors
TargetsCytokines
Therapy Area/IndicationsInflammatory Bowel Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCellics Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesCellics Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsInflammatory Bowel Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A